Literature DB >> 1616397

Immune status during albendazole therapy for hydatidosis.

R M Matossian1, G N Awar, H Radwan, P S Craig, G A Meshefedjian.   

Abstract

Immunological monitoring of cystic hydatid patients undergoing medico-surgical management has revealed that it is possible to assess individual host responses throughout therapy and subsequently be guided by the results obtained. The analysis has involved the demonstration of variation in haemagglutination antibodies, specific IgG and IgM immunoglobulins and circulating immune complexes before, during, and months after albendazole therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616397     DOI: 10.1080/00034983.1992.11812632

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  4 in total

1.  Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.

Authors:  R Riganò; S Ioppolo; E Ortona; P Margutti; E Profumo; M D Ali; B Di Vico; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  Diagnosis and treatment of human hydatidosis.

Authors:  H Wen; R R New; P S Craig
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

3.  Human cystic echinococcosis: old problems and new perspectives.

Authors:  Alessandra Siracusano; Antonella Teggi; Elena Ortona
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-11-01

Review 4.  Immunology and immunodiagnosis of cystic echinococcosis: an update.

Authors:  Wenbao Zhang; Hao Wen; Jun Li; Renyong Lin; Donald P McManus
Journal:  Clin Dev Immunol       Date:  2011-12-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.